TRAF6 and Parkinson disease: Studies in animal models of Parkinson’s disease have also found that activation of the Toll-like receptor 4/TNF receptor-associated factor 6 (TRAF6)-mediated MAPK signaling pathway is involved in neuroinflammatory processes (96).